Gilead Sciences, Inc.
NON-CODING IMMUNOMODULATORY DNA CONSTRUCT

Last updated:

Abstract:

The present invention relates to a nucleic acid molecule and its use for the modulation of the immune system. It provides a DNA construct for immunomodulation comprising at least one nucleotide in L-conformation.

Status:
Application
Type:

Utility

Filling date:

11 Sep 2020

Issue date:

4 Nov 2021